Interferon-α and pericardial injury: a case report and literature review

Por Hakim, Fayaz A, Singh, Sujata, Pandit, Anil, Alegria, Jorge R, Camoriano, John, Stanton, Melissa L, Mookadam, Farouk
Publicado no Heart Asia (2014)

Gemcitabine and Doxetaxel for Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group (NCCTG) Clinical Trial

Por Alberts, Steven R., Reid, Joel M., Morlan, Bruce W., Farr, Gist H., Camoriano, John K., Johnson, David B., Egner, James R., Seay, Thomas E., Kim, George P.
Publicado em 2012

The Clinical Spectrum of Castleman's Disease

Por Dispenzieri, Angela, Armitage, James O., Loe, Matt J, Geyer, Susan M., Allred, Jake, Camoriano, John K., Menke, David M., Weisenburger, Dennis D., Ristow, Kay, Dogan, Ahmet, Habermann, Thomas M.
Publicado em 2012

A Phase II Study of Gemcitabine in Combination with Tanespimycin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinoma

Por Wahner Hendrickson, Andrea E., Oberg, Ann L., Glaser, Gretchen, Camoriano, John K., Peethambaram, Prema P., Colon-Otero, Gerardo, Erlichman, Charles, Ivy, Percy, Kaufmann, Scott H., Karnitz, Larry M., Haluska, Paul
Publicado em 2011

Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients

Por Gowin, Krisstina, Thapaliya, Prakash, Samuelson, Jan, Harrison, Claire, Radia, Deepti, Andreasson, Bjorn, Mascarenhas, John, Rambaldi, Alessandro, Barbui, Tiziano, Rea, Catherine J., Camoriano, John, Gentry, Amy, Kiladjian, Jean-Jacques, O'Connell, Casey, Mesa, Ruben
Publicado em 2012

The Myelofibrosis Symptom Assessment Form (MFSAF): An Evidence-based Brief Inventory to Measure Quality of Life and Symptomatic Response to Treatment in Myelofibrosis

Por Mesa, Ruben A., Schwager, Susan, Radia, Deepti, Cheville, Andrea, Hussein, Kebede, Niblack, Joyce, Pardanani, Animesh D., Steensma, David P., Litzow, Mark R., Rivera, Candido E., Camoriano, John, Verstovsek, Srdan, Sloan, Jeffrey, Harrison, Claire, Kantarjian, Hagop, Tefferi, Ayalew
Publicado no Leuk Res (2009)

Phase II Trial of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Relapsed or Refractory Waldenström Macroglobulinemia

Por Ghobrial, Irene M., Gertz, Morie, LaPlant, Betsy, Camoriano, John, Hayman, Suzanne, Lacy, Martha, Chuma, Stacey, Harris, Brianna, Leduc, Renee, Rourke, Meghan, Ansell, Stephen M., DeAngelo, Daniel, Dispenzieri, Angela, Bergsagel, Leif, Reeder, Craig, Anderson, Kenneth C., Richardson, Paul G., Treon, Steven P., Witzig, Thomas E.
Publicado em 2010